tiprankstipranks
Tempest Therapeutics (TPST)
NASDAQ:TPST
US Market
TPST
Tempest Therapeutics
RESEARCH TOOLSreports

Tempest Therapeutics (TPST) Financial Statements

1,263 Followers

Tempest Therapeutics Financial Overview

Tempest Therapeutics's market cap is currently $29.41M. The company's EPS TTM is $-0.31; its P/E ratio is -0.45; Tempest Therapeutics is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -389.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -26.57M$ -42.03M$ -29.16M$ -34.64M$ -26.99M
EBITDA$ -25.79M$ -40.14M$ -27.66M$ -33.45M$ -26.65M
Net Income$ -26.26M$ -41.84M$ -29.49M$ -35.71M$ -28.30M
Balance Sheet
Cash & Short-Term Investments$ 7.71M$ 30.27M$ 39.23M$ 31.23M$ 51.83M
Total Assets$ 16.93M$ 41.49M$ 51.60M$ 46.09M$ 73.24M
Total Debt$ 8.14M$ 15.37M$ 20.66M$ 22.11M$ 18.54M
Net Debt$ 434.00K$ -14.90M$ -18.57M$ -9.12M$ -33.29M
Total Liabilities$ 10.26M$ 22.36M$ 24.84M$ 27.98M$ 37.12M
Stockholders' Equity$ 6.67M$ 19.13M$ 26.77M$ 18.11M$ 36.12M
Cash Flow
Free Cash Flow$ -26.82M$ -33.46M$ -27.53M$ -31.63M$ -26.09M
Operating Cash Flow$ -26.82M$ -33.03M$ -27.36M$ -31.07M$ -25.96M
Investing Cash Flow$ 0.00$ -435.00K$ -170.00K$ -562.00K$ -97.00K
Financing Cash Flow$ 4.26M$ 24.50M$ 35.60M$ 11.40M$ 59.06M
Currency in USD

Tempest Therapeutics Earnings and Revenue History

Income Statement >

Tempest Therapeutics Debt to Assets

Balance Sheet >

Tempest Therapeutics Cash Flow

Cash Flow >

Tempest Therapeutics Forecast EPS vs Actual EPS

Earnings >